Porter CD - Search Results

1

Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.

Larkin JM, Norsworthy PJ, A'Hern RP, Eisen TG, Gore ME, Porter CD. Larkin JM, et al. Among authors: porter cd. Melanoma Res. 2006 Apr;16(2):157-63. doi: 10.1097/01.cmr.0000200490.62723.b0. Melanoma Res. 2006. PMID: 16567971

2

Mice are unsuitable for modelling ABO discordance despite strain-specific A cross-reactive natural IgM.

Larkin JM, Porter CD. Larkin JM, et al. Among authors: porter cd. Br J Haematol. 2005 Jul;130(2):310-7. doi: 10.1111/j.1365-2141.2005.05609.x. Br J Haematol. 2005. PMID: 16029461 Free article.

3

Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.

Larkin JM, Porter CD. Larkin JM, et al. Among authors: porter cd. Cancer Immunol Immunother. 2007 Jan;56(1):60-9. doi: 10.1007/s00262-006-0174-2. Epub 2006 May 20. Cancer Immunol Immunother. 2007. PMID: 16715304 Free PMC article.

4

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors.

Patel PM, Flemming CL, Fisher C, Porter CD, Thomas JM, Gore ME, Collins MK. Patel PM, et al. Among authors: porter cd. Hum Gene Ther. 1994 May;5(5):577-84. doi: 10.1089/hum.1994.5.5-577. Hum Gene Ther. 1994. PMID: 8054375

5

Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.

Jäger U, Takeuchi Y, Porter C. Jäger U, et al. Gene Ther. 1999 Jun;6(6):1073-83. doi: 10.1038/sj.gt.3300934. Gene Ther. 1999. PMID: 10455410

6

Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Takeuchi Y, Liong SH, Bieniasz PD, Jäger U, Porter CD, Friedman T, McClure MO, Weiss RA. Takeuchi Y, et al. Among authors: porter cd. J Virol. 1997 Aug;71(8):6174-8. doi: 10.1128/JVI.71.8.6174-6178.1997. J Virol. 1997. PMID: 9223512 Free PMC article.

7

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset FL, Weiss RA, Collins MK. Takeuchi Y, et al. Among authors: porter cd. Nature. 1996 Jan 4;379(6560):85-8. doi: 10.1038/379085a0. Nature. 1996. PMID: 8538747

8

Sensitization of human cells to lysis by human complement as an approach for cancer gene therapy.

Jäger U, Takeuchi Y, Porter CD. Jäger U, et al. Among authors: porter cd. Adv Exp Med Biol. 1998;451:359-63. doi: 10.1007/978-1-4615-5357-1_56. Adv Exp Med Biol. 1998. PMID: 10026897 No abstract available.

9

Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery.

Agrawal VK, Copeland KM, Barbachano Y, Rahim A, Seth R, White CL, Hingorani M, Nutting CM, Kelly M, Harris P, Pandha H, Melcher AA, Vile RG, Porter C, Harrington KJ. Agrawal VK, et al. Gene Ther. 2009 Jan;16(1):78-92. doi: 10.1038/gt.2008.140. Epub 2008 Sep 11. Gene Ther. 2009. PMID: 18784747

10

Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.

Mavria G, Jäger U, Porter CD. Mavria G, et al. Among authors: porter cd. Gene Ther. 2000 Mar;7(5):368-76. doi: 10.1038/sj.gt.3301093. Gene Ther. 2000. PMID: 10694818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters